7McCuen BW, Bessler M, Tano Y, et al. The lack of toxicity of intravitreally administered triamcinolone acetonide. Am J Ophthalmol, 1981, 91(6):785-788.
8Enaida H, Sakamoto T, Ueno A, Submacular deposition oftriamcinolone acetonide aftertriamcinolone-assisted vitrectomy. Am J Ophthalmol, 2003,135(2):243-246.
9Jonas JB. Concentration of intravitreally injected triamcinolone acetonide in intraocular silicone oil. Br J Ophthahnol, 2002, 86( 12): 1450-1451.
10Kim H Csaky KG; Gravlin L,et al.Safety and pharmacokinetics of a preservative-free triamcinolone acetonide formulation for intravitreal administration. Retina. 2006,26(5):523-30.
8Dong F T, Sui R F. Surgical management of macular epiretinal memebranesE J ]. Eye Science, 1966, 12 (3) : 140-144.
9唐世波.黄斑部疾病手术学[M].北京:人民卫生出版社,2005:191-199.
10Pesin S R, Olk R J, Grand M G, et al. Vitrectomy for premacular fibroplasia. Prognostic factors, long-term fol- low-up, and time course of visual improvementE J]. Oph- thalmology, 1991, 98(7) :1109-1114.
